State Street’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $85.5M | Sell |
4,017,697
-833,691
| -17% | -$17.7M | ﹤0.01% | 1393 |
|
|
2025
Q1 | $93.6M | Sell |
4,851,388
-751,522
| -13% | -$14.5M | ﹤0.01% | 1300 |
|
|
2024
Q4 | $100M | Buy |
5,602,910
+2,134,396
| +62% | +$38.1M | ﹤0.01% | 1329 |
|
|
2024
Q3 | $76M | Sell |
3,468,514
-654,623
| -16% | -$14.3M | ﹤0.01% | 1485 |
|
|
2024
Q2 | $32.2M | Sell |
4,123,137
-3,991,093
| -49% | -$31.1M | ﹤0.01% | 1894 |
|
|
2024
Q1 | $33.6M | Buy |
8,114,230
+5,658,062
| +230% | +$23.4M | ﹤0.01% | 1930 |
|
|
2023
Q4 | $6.41M | Buy |
2,456,168
+189,599
| +8% | +$495K | ﹤0.01% | 2828 |
|
|
2023
Q3 | $4.24M | Buy |
2,266,569
+12,594
| +0.6% | +$23.6K | ﹤0.01% | 2997 |
|
|
2023
Q2 | $5.66M | Buy |
2,253,975
+2,131,675
| +1,743% | +$5.35M | ﹤0.01% | 2935 |
|
|
2023
Q1 | $214K | Buy |
122,300
+34,400
| +39% | +$60.2K | ﹤0.01% | 4057 |
|
|
2022
Q4 | $374K | Buy |
+87,900
| New | +$374K | ﹤0.01% | 3865 |
|
|
2022
Q2 | – | Sell |
-313,401
| Closed | -$768K | – | 4970 |
|
|
2022
Q1 | $768K | Sell |
313,401
-23,713
| -7% | -$58.1K | ﹤0.01% | 3891 |
|
|
2021
Q4 | $907K | Buy |
337,114
+916
| +0.3% | +$2.46K | ﹤0.01% | 3838 |
|
|
2021
Q3 | $1.68M | Buy |
336,198
+79,498
| +31% | +$398K | ﹤0.01% | 3655 |
|
|
2021
Q2 | $1.92M | Buy |
+256,700
| New | +$1.92M | ﹤0.01% | 3556 |
|